Femasys Inc.
About
What does Femasys Inc. do?
Femasys Inc. (Nasdaq: FEMY) is a biomedical innovator focused on transforming women's reproductive healthcare. The company develops and commercializes a suite of product candidates, including minimally invasive, in-office technologies for fertility treatment and permanent birth control, as well as diagnostic tools. Their solutions aim to expand access to care, improve outcomes, and reduce costs for women worldwide.
What is Femasys Inc.'s Effective Domain Rating?
StartupHub's Effective Domain Rating for Femasys Inc. is 54 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 39, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.
Is Femasys Inc. trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Femasys Inc. is 71 out of 100, based on site security posture and privacy practices.
What is Femasys Inc.'s revenue?
StartupHub estimates Femasys Inc.'s annual revenue at $4.0M (range $2.1M to $18.8M, 27% confidence), based on comparable companies in the sector.
What is Femasys Inc.'s valuation?
StartupHub estimates Femasys Inc.'s effective valuation at $131.9M (range $85.0M to $204.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Femasys Inc. raised?
Femasys Inc. has raised a total of $34M in funding. The most recent round on record is IPO.
Where is Femasys Inc. headquartered?
Femasys Inc. is headquartered in Suwanee, United States.
When was Femasys Inc. founded?
Femasys Inc. was founded in 2004.
What industry does Femasys Inc. operate in?
Femasys Inc. operates in MedTech, Biotech, Women's Health, Reproductive Health, Medical Devices, Fertility Treatment.
An AI copilot for doctors that provides immediate, evidence-based answers to clinical questions from peer-reviewed medical sources.
Aetios AI builds advanced clinical tools for mental health professionals, leveraging AI for psychological formulation and treatment planning.
Ship of Theseus is developing a fleet of biologics based on the homeobox (HOX) family of transcription factors to create novel pharmaceuticals.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Your health consultation for a pain-free life, offering pain management and therapy solutions.
An AI-powered platform for cancer patients and survivors in Asia to navigate care and understand their diagnosis.
AI-powered personalized sleep coaching and actionable insights for improving sleep quality.
An entrant is a company tagged MedTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 4 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.